Exciting news! The revolutionary botulinum toxin Relfydess™ by GALDERMA has been approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). Relfydess is set to transform wrinkle treatments.
This innovative Relfydess treatment is designed to smooth moderate to severe facial lines, providing faster, longer-lasting results.
What Is Relfydess™?
Relfydess™ is a ready-to-use botulinum toxin type A injection.
Unlike traditional formulations, Relfydess requires no mixing, ensuring precise and consistent dosing. Each vial contains 150 units of botulinum toxin in 1.5 mL of solution, specifically formulated for targeted wrinkle treatments.
How Does Relfydess™ Work?
Relfydess™ works by temporarily relaxing the muscles responsible for wrinkles. The treatment is especially effective for:
- Glabellar Lines: The vertical frown lines between the eyebrows.
- Lateral Canthal Lines: Crow’s feet around the eyes.
- Combination Areas: Both glabellar and lateral canthal lines treated together.
The solution is injected into specific muscles using detailed techniques to ensure safety and accuracy. Most patients notice results within 1 to 3 days, with some seeing changes in just 24 hours.
What Makes Relfydess™ Unique?
Relfydess™ brings several advantages over existing wrinkle treatments:
- Fast Onset: Effects can start in as little as one day.
- Long-Lasting Results: Results last up to six months for most patients, reducing the need for frequent appointments.
- Precision Dosing: The ready-to-use formula eliminates the need for reconstitution, enhancing consistency.
- Improved Patient Satisfaction: Clinical trials reported a significant boost in psychological well-being and confidence among patients.
Clinical Evidence You Can Trust
Relfydess™ has undergone rigorous clinical testing in over 1,700 patients during its phase III trials, validating the effectiveness and safety of Relfydess for targeted wrinkle treatments. Here are some highlights:
- Fast Results: Up to 39% of patients saw improvements in glabellar lines within one day.
- Longevity: Six months post-treatment, 75% of patients had not returned to baseline wrinkle severity.
- Safety: Side effects were mild to moderate, such as slight redness or swelling at the injection site, occurring in less than 7% of patients.
For more details, check the full study results on the MHRA Yellow Card Scheme.
Who Can Benefit from Relfydess™?
Relfydess™ is ideal for adults under 65 who want to smooth moderate to severe wrinkles. It’s not suitable for individuals with neuromuscular conditions or hypersensitivity to botulinum toxins. Treatments are tailored to individual needs, ensuring the best results for Relfydess patients.